Client commercialization launch was in need of:
We took a consultative strategic approach with the client and jointly developed the overall go-to-market strategy to maximize awareness of the company’s mission and to ensure successful launch of their first product to market.
PROPENSITY4 used de-identified claims data to identify the optimal targeting scheme and channel mix strategy to build optimal strategy and call plans.
Built a compliant data warehouse to support Medical Affairs (firewalled), Market Access, Sales, Marketing, and Trade/Distribution using >35 different data sources.
Built baseline and most probable financial forecasts and assessed overall near term and long-term market opportunity.
Developed sales force size/structure and territory design based on FDA approved indications and market opportunity.
Used available data to determine the optimal channel (virtual, field, digital) to reach customers with the right message, the right reach, and the right frequency.
The team’s Promotional Response analysis leveraged SMART data to discover that HCPs need to receive 8-10 calls prior to writing their first prescription of the novel launch therapy.
Call guidance was balanced to workload, allocating appropriate variable call plans to grow, maintain, and prospect targets.
CASE STUDY (US) Propensity4 improves forecast transparency for first in class induced constipation product.
CASE STUDY (US) Inside sales team delivers highest RX lift during 6-month pilot for mature brand product facing LOE.
CASE STUDY (US) Seamless transition of US Medical Information program handled 98K calls within the first year.